<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Management of high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> in <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> is controversial: surgery carries an appreciable morbidity/mortality, high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> may not progress to <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> and endoscopic ablation is an emerging option </plain></SENT>
<SENT sid="1" pm="."><plain>AIM: To review <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e>-related high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> management and outcome over a 10-year period </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: This was a retrospective case note review of 36 patients identified from a pathology database </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: There were 31 men of mean age 67 years </plain></SENT>
<SENT sid="4" pm="."><plain>Endoscopic surveillance identified nine </plain></SENT>
<SENT sid="5" pm="."><plain>Median follow-up was 21 months </plain></SENT>
<SENT sid="6" pm="."><plain>Seven patients had no further intervention because of age/comorbidity </plain></SENT>
<SENT sid="7" pm="."><plain>The other 29 had repeat endoscopic biopsies, nine showing <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> (six oesophagectomized) </plain></SENT>
<SENT sid="8" pm="."><plain>Of the 20 remaining patients with persisting high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, eight had surgery (histology showed <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> in six), seven continued endoscopic surveillance (high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> regressed in four) and five had 'curative' <z:chebi fb="17" ids="49474,49475">argon</z:chebi> ablation </plain></SENT>
<SENT sid="9" pm="."><plain>An intensive biopsy protocol was not followed in 55% of endoscopies </plain></SENT>
<SENT sid="10" pm="."><plain>Prevalent <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> occurred in 44% with an annual incidence of 5% over 5 years </plain></SENT>
<SENT sid="11" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> cause mortality was 39% (14 of 36, eight of 14 from <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>) </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSIONS: Management of high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> was not uniform </plain></SENT>
<SENT sid="13" pm="."><plain>Unsuspected <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> was common in high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> patients undergoing surgery but 13% regressed under surveillance </plain></SENT>
<SENT sid="14" pm="."><plain>High-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> patients have a high mortality but 43% did not die from <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
</text></document>